MARA Holdings
MARA
Microsoft
MSFT
Salesforce
CRM
Apple
AAPL
KB Home
KBH
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 5.280
- +0.180+3.53%
Trading Dec 12 12:29 ET
156.34MMarket Cap-6.81P/E (TTM)
5.380High5.101Low56.83KVolume5.360Open5.100Pre Close298.79KTurnover0.33%Turnover RatioLossP/E (Static)29.61MShares20.72052wk High352.00P/B92.22MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM5.48%Amplitude3.110Historical Low5.257Avg Price1Lot Size
Telomir Pharmaceuticals News
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jerman Michael Allen
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MacPherson Edward Clouston
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Yanez Michelle
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Whalen Matthew Pratt
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.